Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies

被引：30
|
作者：
Ochoa, Sebastian [1 ]
Ding, Li [1 ]
Kreuzburg, Samantha [1 ]
Treat, Jennifer [2 ]
Holland, Steven M. [1 ]
Zerbe, Christa S. [1 ]
机构：
[1] NIAID, Lab Clin Immunol & Microbiol, Div Intramural Res, NIH, Bethesda, MD 20892 USA
[2] Med Sci & Comp, Rockville, MD USA
来源：
CLINICAL INFECTIOUS DISEASES | 2021年 / 72卷 / 12期
基金：
美国国家卫生研究院;
关键词：
daratumumab; mycobacteria; disseminated; interferon gamma; autoantibodies;
D O I：
10.1093/cid/ciaa1086
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Patients with autoantibodies to interferon-gamma (IFN-gamma) may develop severe nontuberculous mycobacterial infections. We describe the novel use of daratumumab in a patient with autoantibodies to IFN-gamma who had progressive infection, resulting in clinical and radiographic improvement.
引用
收藏
页码：2206 / 2208
页数：3
相关论文
共 50 条
  • [1] DARATUMUMAB Anti-CD38 Monoclonal Antibody, Treatment of Multiple Myeloma
    Richardson, P.
    Lokhorst, H.
    Palumbo, A.
    Nahi, H.
    Laubach, J.
    Gimsing, P.
    Lisby, S.
    Cakana, A.
    Brun, N. Constantin
    Plesner, T.
    DRUGS OF THE FUTURE, 2013, 38 (08) : 545 - 554
  • [2] Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon- autoantibodies and disseminated nontuberculous mycobacterial infections
    Chi, Chih-Yu
    Lin, Chia-Hao
    Ho, Mao-Wang
    Ding, Jing-Ya
    Huang, Wen-Chi
    Shih, Han-Po
    Yeh, Chun-Fu
    Fung, Chang-Phone
    Sun, Hsin-Yun
    Huang, Ching-Tai
    Wu, Ting-Shu
    Chang, Chih-Yen
    Liu, Yuag-Meng
    Feng, Jia-Yih
    Wu, Wei-Kai
    Wang, Lih-Shinn
    Tsai, Chung-Hao
    Ho, Cheng-Mao
    Lin, Huang-Shen
    Chen, Hung-Jen
    Lin, Po-Chang
    Liao, Wei-Chin
    Chen, Wei-Ting
    Lo, Chia-Chi
    Wang, Shang-Yu
    Kuo, Chen-Yen
    Lee, Chen-Hsiang
    Ku, Cheng-Lung
    MEDICINE, 2016, 95 (25)
  • [3] Rituximab as Successful Adjunct Treatment in a Patient With Disseminated Nontuberculous Mycobacterial Infection Due to Acquired Anti-Interferon-γ Autoantibody
    Czaja, Christopher A.
    Merkel, Patricai A.
    Chan, Edward D.
    Lenz, Laurel L.
    Wolf, Molly L.
    Alam, Rafeul
    Frankel, Stephen K.
    Fischer, Aryeh
    Gogate, Shaila
    Perez-Velez, Carlos M.
    Knight, Vijaya
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (06) : E115 - E118
  • [4] Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
    Saltarella, Ilaria
    Desantis, Vanessa
    Melaccio, Assunta
    Solimando, Antonio Giovanni
    Lamanuzzi, Aurelia
    Ria, Roberto
    Storlazzi, Clelia Tiziana
    Mariggio, Maria Addolorata
    Vacca, Angelo
    Frassanito, Maria Antonia
    CELLS, 2020, 9 (01)
  • [5] Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab
    Thirkettle, Sally
    Russell, Joanne
    Wilson, Sarah
    Ganijee, Tasneem
    Kulkarni, Samar
    Cavet, Jim
    Monaghan, Phillip J.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2020, 57 (02) : 178 - 181
  • [6] Disseminated Talaromyces marneffei And Mycobacterium avium Infection Accompanied Sweet's Syndrome In A Patient With Anti-Interferon-γ Autoantibodies: A Case Report
    Su, Shan-Shan
    Zhang, Sheng-Nan
    Ye, Jun-Ru
    Xu, Ling-Na
    Lin, Peng-Cheng
    Xu, Han-Yan
    Wu, Qing
    Li, Yu-Ping
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 3189 - 3195
  • [7] Treatment of Multiple Myeloma in Patients Refractory to Daratumumab/Anti-CD38 Monoclonal Antibodies: A Systematic Review
    Tan, Chia Jie
    Kacerek, Dylan
    Kampirapawong, Nattawara
    Godara, Amandeep
    Chaiyakunapruk, Nathorn
    CANCER MEDICINE, 2025, 14 (05):
  • [8] Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma
    Jutatip Panaampon
    Ryusho Kariya
    Seiji Okada
    Cancer Immunology, Immunotherapy, 2022, 71 : 1017 - 1031
  • [9] Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma
    Panaampon, Jutatip
    Kariya, Ryusho
    Okada, Seiji
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (05) : 1017 - 1031
  • [10] Case report: serological testing interference of daratumumab (anti-CD38) therapy in multiple myeloma
    Rabut, Elodie
    Castro-Fernandez, Annabelle
    Le Gall, Virginie
    Meknache, Nihad
    ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (03) : 351 - 355
12345